DNA

6.33

0.63% -0.04

Handel nachbörslich: 6.37 0.04 +0.63%

Ginkgo Bioworks Holdings Inc (DNA)

Überblick Nachrichten Preisverlauf Optionskette Warum fällt DNA? Forum Prognose

Schlusskurs vom Vortag:

$6.37

Offen:

$6.43

24-Stunden-Volumen:

1.75M

Relative Volume:

1.21

Marktkapitalisierung:

$351.79M

Einnahmen:

$217.11M

Nettoeinkommen (Verlust:

$-651.19M

KGV:

-8.9155

EPS:

-0.71

Netto-Cashflow:

$-387.26M

1W Leistung:

-27.74%

1M Leistung:

-28.72%

6M Leistung:

-80.36%

1J Leistung:

-89.59%

1-Tages-Spanne:

$6.0904

$6.55

1-Wochen-Bereich:

$6.01

$10.07

52-Wochen-Spanne:

$5.26

$75.20

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Firmenname

Ginkgo Bioworks Holdings Inc

Sektor

Healthcare (1196)

Branche

Biotechnology (683)

Telefon

(877) 442-5362

Adresse

27 DRYDOCK AVENUE, BOSTON

Mitarbeiter

1,218

Twitter

Nächster Verdiensttermin

2024-08-08

Neueste SEC-Einreichungen

DNA's Discussions on Twitter

Vergleichen Sie DNA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
DNA	6.33	351.79M	217.11M	-651.19M	-387.26M	-0.71
VRTX	467.01	119.87B	10.63B	-479.80M	-1.35B	13.33
REGN	762.00	83.27B	13.85B	4.65B	3.32B	35.06
ARGX	567.90	33.96B	1.86B	-40.29M	-1.28B	-4.16
ALNY	232.27	30.18B	2.09B	-332.26M	16.06M	-4.14
BNTX	101.87	24.42B	3.30B	-501.07M	1.03B	11.54

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-05-15	Herabstufung	BTIG Research	Neutral → Sell
2024-05-10	Herabstufung	William Blair	Mkt Perform → Underperform
2023-11-14	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-11-09	Herabstufung	BTIG Research	Buy → Neutral
2023-06-02	Herabstufung	Goldman	Neutral → Sell
2023-05-11	Herabstufung	William Blair	Outperform → Mkt Perform
2022-11-29	Eingeleitet	Berenberg	Buy
2022-10-04	Eingeleitet	Morgan Stanley	Equal-Weight
2022-05-18	Herabstufung	BofA Securities	Neutral → Underperform
2022-03-02	Fortgesetzt	Cowen	Outperform
2022-02-23	Eingeleitet	Goldman	Neutral
2022-02-01	Eingeleitet	BofA Securities	Neutral
2022-01-28	Eingeleitet	BofA Securities	Buy
2022-01-07	Eingeleitet	BTIG Research	Buy
2021-11-29	Eingeleitet	Jefferies	Buy
2021-10-13	Eingeleitet	Raymond James	Outperform
2021-10-12	Eingeleitet	William Blair	Outperform
2021-09-20	Eingeleitet	HSBC Securities	Buy

Alle ansehen

Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten

04:10 AM

How To Trade (DNA) - Stock Traders Daily

04:10 AM

10:36 AM

Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better (NYSE:DNA) - Seeking Alpha

10:36 AM

07:52 AM

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Sees Significant Drop in Short Interest - MarketBeat

07:52 AM

Nov 16, 2024

GSA Capital Partners LLP Has $979,000 Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Simply Wall St

Nov 15, 2024

Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 15, 2024

Nov 13, 2024

Ginkgo cancels move to new South Boston lab, exits Cambridge office - MassLive.com

Nov 13, 2024

Ginkgo Bioworks Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2024 Earnings Call Transcript - MSN

Nov 13, 2024

Ginkgo Bioworks: Not Enough Progress (NYSE:DNA) - Seeking Alpha

Nov 13, 2024

Baillie Gifford & Co. Sells 131,067,285 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - MarketBeat

Nov 13, 2024

Nov 12, 2024

Ginkgo Bioworks Reports Q3 Growth and Strategic Deals - TipRanks

Nov 12, 2024

Ginkgo nixes move to South Boston lab, will exit Cambridge sites. Here's what it means - NBC Boston

Nov 12, 2024

Ginkgo nixes move to South Boston lab, will exit Cambridge sites - The Business Journals

Nov 12, 2024